These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

118 related articles for article (PubMed ID: 38062507)

  • 1. Impact of specialist ataxia centres on health service resource utilisation and costs across Europe: cross-sectional survey.
    Morris S; Vallortigara J; Greenfield J; Hunt B; Hoffman D; Reinhard C; Graessner H; Federico A; Quoidbach V; Giunti P
    Orphanet J Rare Dis; 2023 Dec; 18(1):382. PubMed ID: 38062507
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Patient pathways for rare diseases in Europe: ataxia as an example.
    Vallortigara J; Greenfield J; Hunt B; Hoffman D; Reinhard C; Graessner H; Federico A; Quoidbach V; Morris S; Giunti P
    Orphanet J Rare Dis; 2023 Oct; 18(1):328. PubMed ID: 37848998
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Understanding the socioeconomic costs of dystrophic epidermolysis bullosa in Europe: a costing and health-related quality of life study.
    Angelis A; Mellerio JE; Kanavos P
    Orphanet J Rare Dis; 2022 Sep; 17(1):346. PubMed ID: 36068590
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Impact of Friedreich's Ataxia on health-care resource utilization in the United Kingdom and Germany.
    Giunti P; Greenfield J; Stevenson AJ; Parkinson MH; Hartmann JL; Sandtmann R; Piercy J; O'Hara J; Casas LR; Smith FM
    Orphanet J Rare Dis; 2013 Feb; 8():38. PubMed ID: 23448170
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Economic impact of healthcare resource utilisation patterns among patients diagnosed with advanced melanoma in the United Kingdom, Italy, and France: results from a retrospective, longitudinal survey (MELODY study).
    Johnston K; Levy AR; Lorigan P; Maio M; Lebbe C; Middleton M; Testori A; Bédane C; Konto C; Dueymes A; Sbarigia U; van Baardewijk M
    Eur J Cancer; 2012 Sep; 48(14):2175-82. PubMed ID: 22480965
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Integration, effectiveness and costs of different models of primary health care provision for people who are homeless: an evaluation study.
    Crane M; Joly L; Daly BJ; Gage H; Manthorpe J; Cetrano G; Ford C; Williams P
    Health Soc Care Deliv Res; 2023 Oct; 11(16):1-217. PubMed ID: 37839804
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Direct medical mental health care costs of schizophrenia in France, Germany and the United Kingdom - findings from the European Schizophrenia Cohort (EuroSC).
    Heider D; Bernert S; König HH; Matschinger H; Hogh T; Brugha TS; Bebbington PE; Azorin M; Angermeyer MC; Toumi M
    Eur Psychiatry; 2009 May; 24(4):216-24. PubMed ID: 19328658
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Healthcare resource utilisation and medical costs for children with interstitial lung diseases (chILD) in Europe.
    Seidl E; Schwerk N; Carlens J; Wetzke M; Cunningham S; Emiralioğlu N; Kiper N; Lange J; Krenke K; Ullmann N; Krikovszky D; ; Maqhuzu P; Griese CA; Schwarzkopf L; Griese M
    Thorax; 2022 Aug; 77(8):781-789. PubMed ID: 35149583
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Exploring the costs, consequences and efficiency of three types of palliative care day services in the UK: a pragmatic before-and-after descriptive cohort study.
    Mitchell PM; Coast J; Myring G; Ricciardi F; Vickerstaff V; Jones L; Zafar S; Cudmore S; Jordan J; McKibben L; Graham-Wisener L; Finucane AM; Hewison A; Haraldsdottir E; Brazil K; Kernohan WG
    BMC Palliat Care; 2020 Aug; 19(1):119. PubMed ID: 32767979
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Medical resource utilisation and cost of care for women seeking treatment for urinary incontinence in an outpatient setting. Examples from three countries participating in the PURE study.
    Papanicolaou S; Pons ME; Hampel C; Monz B; Quail D; Schulenburg MG; Wagg A; Sykes D
    Maturitas; 2005 Nov; 52 Suppl 2():S35-47. PubMed ID: 16297577
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Social/economic costs and health-related quality of life in patients with epidermolysis bullosa in Europe.
    Angelis A; Kanavos P; López-Bastida J; Linertová R; Oliva-Moreno J; Serrano-Aguilar P; Posada-de-la-Paz M; Taruscio D; Schieppati A; Iskrov G; Brodszky V; von der Schulenburg JM; Chevreul K; Persson U; Fattore G;
    Eur J Health Econ; 2016 Apr; 17 Suppl 1(Suppl 1):31-42. PubMed ID: 27107597
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A randomised controlled multicentre trial of treatments for adolescent anorexia nervosa including assessment of cost-effectiveness and patient acceptability - the TOuCAN trial.
    Gowers SG; Clark AF; Roberts C; Byford S; Barrett B; Griffiths A; Edwards V; Bryan C; Smethurst N; Rowlands L; Roots P
    Health Technol Assess; 2010 Mar; 14(15):1-98. PubMed ID: 20334748
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Social/economic costs and quality of life in patients with haemophilia in Europe.
    Cavazza M; Kodra Y; Armeni P; De Santis M; López-Bastida J; Linertová R; Oliva-Moreno J; Serrano-Aguilar P; Posada-de-la-Paz M; Taruscio D; Schieppati A; Iskrov G; Gulácsi L; von der Schulenburg JM; Kanavos P; Chevreul K; Persson U; Fattore G;
    Eur J Health Econ; 2016 Apr; 17 Suppl 1():53-65. PubMed ID: 27048374
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Healthcare resource utilization and costs for multiple sclerosis management in the Campania region of Italy: Comparison between centre-based and local service healthcare delivery.
    Moccia M; Tajani A; Acampora R; Signoriello E; Corbisiero G; Vercellone A; Sergianni P; Pennino F; Lanzillo R; Palladino R; Capacchione A; Brescia Morra V; Lus G; Triassi M
    PLoS One; 2019; 14(9):e0222012. PubMed ID: 31536513
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Cancer genetics service provision: a comparison of seven European centres.
    Hopwood P; van Asperen CJ; Borreani G; Bourret P; Decruyenaere M; Dishon S; Eisinger F; Evans DG; Evers-Kiebooms G; Gangeri L; Hagoel L; Legius E; Nippert I; Rennert G; Schlegelberger B; Sevilla C; Sobol H; Tibben A; Welkenhuysen M; Julian-Reynier C
    Community Genet; 2003; 6(4):192-205. PubMed ID: 15331865
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Cost of health care for paediatric patients with sickle cell disease: An analysis of resource use and costs in a European country.
    Thielen FW; Houwing ME; Cnossen MH; Al Hadithy-Irgiztseva IA; Hazelzet JA; Groot CAU; de Pagter APJ; Blommestein HM
    Pediatr Blood Cancer; 2020 Sep; 67(9):e28588. PubMed ID: 32672889
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Social/economic costs and health-related quality of life in patients with juvenile idiopathic arthritis in Europe.
    Kuhlmann A; Schmidt T; Treskova M; López-Bastida J; Linertová R; Oliva-Moreno J; Serrano-Aguilar P; Posada-de-la-Paz M; Kanavos P; Taruscio D; Schieppati A; Iskrov G; Péntek M; Delgado C; von der Schulenburg JM; Persson U; Chevreul K; Fattore G;
    Eur J Health Econ; 2016 Apr; 17 Suppl 1():79-87. PubMed ID: 27086322
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Use and cost of hospital and community service provision for children with HIV infection at an English HIV referral centre.
    Beck EJ; Mandalia S; Griffith R; Beecham J; Walters MD; Boulton M; Miller DL
    Pharmacoeconomics; 2000 Jan; 17(1):53-69. PubMed ID: 10747765
    [TBL] [Abstract][Full Text] [Related]  

  • 19.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 20.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 6.